Mathys & Squire LLP

Intellectual property

James’ practice focuses on European Patent Office (EPO) prosecution and opposition work in the life sciences sector. He also has extensive experience with supplementary protection certificates (SPCs) and has prosecuted SPC applications covering a number of blockbuster drugs.

James handles a mix of EPO prosecution and opposition work in the life sciences sector. He has particular expertise in immunology, including antibody-based therapeutics and vaccines, diagnostics, nucleic acid amplification, (oligo) nucleotide therapy, gene editing and plant extracts.  He is experienced in handling EPO opposition proceedings and regularly appears before EPO tribunals on behalf of clients.  James also has extensive experience with SPCs.  He has coordinated prosecution of several SPC/paediatric extension portfolios across Europe, and regularly advises clients in this area, including in relation to SPC disputes.

James is a fellow of the Chartered Institute of Patent Attorneys (CIPA) and member of the European Patent Institute (EPI).

James has a master’s degree in biochemistry and a doctorate on the biochemistry of heart disease, both from Oxford University. James also conducted post-doctoral research at Université Paris-XI on cardiac disease. He is an author of several peer-reviewed papers on this subject.

Recent work